SCHEMBL21687779

SCHEMBL21687779

N#Cc1cc(-c2c(C#N)cccc2[Si](c2ccccc2)(c2ccccc2)c2ccccc2)cc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.33
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
TSHR P16473 4/20 0.33
KDM4E B2RXH2 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CYP1A2 P05177 5/20 0.33
CYP3A4 P08684 4/20 0.33
LMNA P02545 4/20 0.33
CYP2D6 P10635 3/20 0.33
MAPT P10636 3/20 0.33
TP53 P04637 2/20 0.33
HTT P42858 2/20 0.32
STAT3 P40763 1/20 0.32
HSD17B10 Q99714 3/20 0.32
IMPDH2 P12268 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687873 0.95 CYP1A2 (0.32) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL21687973 0.88 KDM4E (0.39) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL21687689 0.86 KDM4E (0.34) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL21688077 0.85 KDM4E (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL21688016 0.84 KDM4E (0.34) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL21687979 0.84 KDM4E (0.36) ALDH1A1MEN1KMT2ATSHRKDM4E
SCHEMBL21687783 0.83 PGR (0.35) ALDH1A1SMN1; SMN2KDM4EL3MBTL1ATM
SCHEMBL21687723 0.83 KDM4E (0.34) ALDH1A1SMN1; SMN2KDM4EL3MBTL1ATM
SCHEMBL21688038 0.83 PGR (0.35) ALDH1A1SMN1; SMN2KDM4ETDP1L3MBTL1
SCHEMBL21688181 0.83 KDM4E (0.36) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 ALDH1A1 616/4885MEN1 669/4885KMT2A 1464/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 ALDH1A1 616/4885MEN1 669/4885KMT2A 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.